
### [NCIT:C7915](http://purl.obolibrary.org/obo/NCIT_C7915)
**Label:** TSH-Producing Pituitary Gland Neoplasm

**Subclasses:** [NCIT:C5965](http://purl.obolibrary.org/obo/NCIT_C5965) (TSH-Producing Pituitary Gland Carcinoma), [NCIT:C8011](http://purl.obolibrary.org/obo/NCIT_C8011) (TSH-Producing Pituitary Gland Adenoma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [CL:0000476](http://purl.obolibrary.org/obo/CL_0000476) (thyrotroph) 52.94%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C32044](http://purl.obolibrary.org/obo/NCIT_C32044) (Acidophilic Cell))) 52.94%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38341](http://purl.obolibrary.org/obo/NCIT_C38341) (Postgerminal Center B-Lymphocyte of Unknown Differentiation Stage))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C3834](http://purl.obolibrary.org/obo/NCIT_C3834) (Ataxic Gait))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38339](http://purl.obolibrary.org/obo/NCIT_C38339) (Postgerminal Center Memory B-Lymphocyte))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38334](http://purl.obolibrary.org/obo/NCIT_C38334) (Postgerminal Center Marginal Zone B-Lymphocyte))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38333](http://purl.obolibrary.org/obo/NCIT_C38333) (Activated B-Lymphocyte))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38332](http://purl.obolibrary.org/obo/NCIT_C38332) (Peripheral B-Lymphocyte of Inner Mantle Zone))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38331](http://purl.obolibrary.org/obo/NCIT_C38331) (Intraepithelial T-Lymphocyte))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38329](http://purl.obolibrary.org/obo/NCIT_C38329) (Thymic B-Lymphocyte))) 38.30%
- [NCIT:C45920](http://purl.obolibrary.org/obo/NCIT_C45920) (Adenohypophysial Cell) and (not ([NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome))) 38.30%


